Literature DB >> 18538096

Acute intermittent porphyria and chronic renal failure.

J T Marsden1, P Chowdhury, J Wang, A Deacon, N Dutt, T J Peters, I C Macdougall.   

Abstract

Despite the little known association between renal damage and the acute porphyrias, limited information is available on the characteristics and pathogenesis of renal disease in this patient group. Previous reports have focused on hypertension as the principal etiological factor. We have studied a series of 9 patients with acute intermittent porphyria (AIP) attending the Porphyria Clinic at King's College Hospital, London, UK, who were referred to the Renal Unit for investigation and treatment of their renal disease. No evidence of a glomerular lesion was found in any of the patients. In contrast, renal histology showed features of a tubulointerstitial disease, and there was evidence of impaired erythropoietin production. Hypertension and nonsteroidal antiinflammatory drug use were present in about a half of the patients. It is postulated that the nephrotoxic effects of porphyrin precursors may contribute to the etiology of this clinical syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18538096     DOI: 10.5414/cnp69339

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

2.  A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.

Authors:  Dimitri Tchernitchko; Quentin Tavernier; Jérôme Lamoril; Caroline Schmitt; Neila Talbi; Said Lyoumi; Anne-Marie Robreau; Zoubida Karim; Laurent Gouya; Eric Thervet; Alexandre Karras; Hervé Puy; Nicolas Pallet
Journal:  J Am Soc Nephrol       Date:  2016-12-28       Impact factor: 10.121

3.  Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms.

Authors:  Joanne T Marsden; Simon Guppy; Penelope Stein; Timothy M Cox; Michael Badminton; Tricia Gardiner; Julian H Barth; M Felicity Stewart; David C Rees
Journal:  JIMD Rep       Date:  2015-03-12

4.  Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.

Authors:  Joanna K Dowman; Bridget K Gunson; Darius F Mirza; Simon R Bramhall; Mike N Badminton; Philip N Newsome
Journal:  Liver Transpl       Date:  2012-02       Impact factor: 5.799

5.  Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.

Authors:  Carmen Unzu; Ana Sampedro; Eliane Sardh; Itsaso Mauleón; Rafael Enríquez de Salamanca; Jesús Prieto; Eduardo Salido; Pauline Harper; Antonio Fontanellas
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 6.  Acute Hepatic Porphyria.

Authors:  D Montgomery Bissell; Bruce Wang
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

Review 7.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01

8.  Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study.

Authors:  Oscar J Pozo; Josep Marcos; Andreu Fabregat; Rosa Ventura; Gregori Casals; Paula Aguilera; Jordi Segura; Jordi To-Figueras
Journal:  Orphanet J Rare Dis       Date:  2014-04-16       Impact factor: 4.123

9.  Porphyria and kidney diseases.

Authors:  Nicolas Pallet; Alexandre Karras; Eric Thervet; Laurent Gouya; Zoubida Karim; Hervé Puy
Journal:  Clin Kidney J       Date:  2018-01-10

10.  Combined Liver and Kidney Transplant in Acute Intermittent Porphyria: A Case Report.

Authors:  Gustavo de Sousa Arantes Ferreira; Livia Claudio de Oliveira; Luiz Roberto de Sousa Ulisses; Andre Luis Conde Watanabe; Isabela Novais Medeiros; Helen Souto Siqueira Cardoso; Inara Creão da Costa Alves; Tiago Martins de Almeida; Laura Viana de Lima; Renata Pereira Fontoura; Eduardo Resende Sousa E Silva; Pollyana Lopes de Araújo
Journal:  Am J Case Rep       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.